Ray Dalio Astrazeneca PLC Transaction History
Bridgewater Associates, LP
- $17.3 Billion
- Q3 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Astrazeneca PLC stock. As of the latest transaction made, Bridgewater Associates, LP holds 205,108 shares of AZN stock, worth $13 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
205,108
Previous 209,177
1.95%
Holding current value
$13 Million
Previous $16.3 Million
2.03%
% of portfolio
0.09%
Previous 0.09%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$3.97 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.65 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.35 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.33 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.22 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $196B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...